Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem in Focal Dystonia
NCT04692285Phase 1Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Sep 2017
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial in focal dystonia comparing Zolpidem First with Placebo First (2 arms). Primary endpoints: Change in transcranial magnetic stimulation measures and Change in brain metabolism detected on FDG-PET CT brain imaging. Started Sep 2017; status: completed.
02
Drugs
zolpidem
03
Conditions
focal dystonia
Beyond the preview
Go deeper on NCT04692285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04692285.